Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/158951
Full metadata record
DC FieldValueLanguage
dc.contributor.authorde la Torre, Beatriz G.-
dc.contributor.authorAlbericio Palomera, Fernando-
dc.date.accessioned2020-05-06T15:36:26Z-
dc.date.available2020-05-06T15:36:26Z-
dc.date.issued2018-02-27-
dc.identifier.issn1420-3049-
dc.identifier.urihttp://hdl.handle.net/2445/158951-
dc.description.abstractThis is an analysis from a chemical point of view of the 46 drugs (34 New Chemical Entities and 12 Biologics) approved by the FDA during 2017. The drugs included in the 2017 "harvest" have been classified on the basis of their chemical structure: biologics (antibodies and proteins); peptides; amino acids and natural products; drug combinations; and small molecules.-
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/molecules23030533-
dc.relation.ispartofMolecules, 2018, vol. 23, num. 3, p. 533-
dc.relation.urihttps://doi.org/10.3390/molecules23030533-
dc.rightscc-by (c) de la Torre, Beatriz G. et al., 2018-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Química Inorgànica i Orgànica)-
dc.subject.classificationDisseny de medicaments-
dc.subject.classificationPèptids-
dc.subject.classificationFarmacologia-
dc.subject.otherDrug design-
dc.subject.otherPeptides-
dc.subject.otherPharmacology-
dc.titleThe Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec680996-
dc.date.updated2020-05-06T15:36:26Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid29495494-
Appears in Collections:Articles publicats en revistes (Química Inorgànica i Orgànica)

Files in This Item:
File Description SizeFormat 
680996.pdf3.57 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons